arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Insulet Corporation

PODD Health Care Medical/Dental Instruments
$145.10
▼ -1.6% Today
as of Sep 4, 16:53 ET
Last 30 days -11.94% Jul 28 → Sep 04
$130.27 $141.11 $151.94 $162.77 $173.61 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$149.32
High
$150.56
Low
$145.42
Volume
$1M
Avg Vol
$1M
Mkt Cap
$10.2B
P/E (TTM)
37.72
Beta
—
52w High
$354.88
52w Low
$126.40
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 25 items

Sep 4 · 15:30 Zacks
Why Is Insulet (PODD) Up 8.1% Since Last Earnings Report?
Sep 4 · 00:39 StockStory
Unpacking Q2 Earnings: Insulet (NASDAQ:PODD) In The Context Of Other Patient Monitoring Stocks
Sep 2 · 20:11 Simply Wall St.
Insulet (PODD) Stock May Be 40% Undervalued On Fair Value Grounds
▸ Show all 25 press releases & news Free account →

Overview

52-week range
$126
$355
8% of range
Avg surprise (last 3)
+25.4%
Avg reaction (last 2)
-6.2%
0% positive
Latest IV / EM
42%
EM ±6.6% · $145 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$0.34$0.90$1.47$2.03$2.59 Actual $0.34Actual $0.39Actual $0.74Actual $0.73Actual $2.59Actual $1.08Actual $1.02Est $0.81Actual $1.17Est $0.93Actual $1.24Actual $1.42Est $1.14Actual $1.37 MarJunSepMarJunSepMar/2025Jun/2025SepMar/2026Jun
Revenue vs Net Income Revenue Net income
$0$210M$421M$631M$842M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $1.37 — — — — financials
Wed May 6, 2026Mar/2026 $1.42 $1.14 +24.6% +39.2% -9.7% earnings
Tue Sep 30, 2025Sep 2025 $1.24 — — — — financials
Thu Aug 7, 2025Jun/2025 $1.17 $0.93 +25.8% — — earnings
Thu May 8, 2025Mar/2025 $1.02 $0.81 +25.9% — -2.8% earnings
Mon Sep 30, 2024Sep 2024 $1.08 — — — — financials
Sun Jun 30, 2024Jun 2024 $2.59 — — — — financials
Sun Mar 31, 2024Mar 2024 $0.73 — — — — financials
Sat Sep 30, 2023Sep 2023 $0.74 — — — — financials
Fri Jun 30, 2023Jun 2023 $0.39 — — — — financials
Fri Mar 31, 2023Mar 2023 $0.34 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$802M$762M—$706M$649M$569M—$544M
Cost of revenue$239M$233M—$196M$197M$160M—$167M
Gross profit$563M$529M—$510M$452M$409M—$377M
Operating income$130M$122M—$118M$121M$89M—$88M
Net income$95M$91M—$88M$22M$35M—$78M
EPS (diluted)$1.37$1.30—$1.24$0.32$0.50—$1.08

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents————————
Inventory$485M$462M$453M$446M$447M$441M$430M$445M
Total current assets$1.85B$1.71B$1.91B$1.86B$2.28B$2.33B$1.89B$1.86B
Total assets$3.17B$2.99B$3.19B$3.03B$3.47B$3.52B$3.09B$3.03B
Long-term debt————————
Total liabilities$1.74B$1.68B$1.68B$1.65B$2.01B$2.19B$1.88B$1.91B
Total equity$1.42B$1.30B$1.52B$1.38B$1.46B$1.33B$1.21B$1.12B

Implied volatility — last 90 days

27%69%111%152%194% Jun 07 — IV 55% · EM ±7.7%Jun 08 — IV 55% · EM ±7.3%Jun 09 — IV 49% · EM ±6.1%Jun 10 — IV 59% · EM ±7.0%Jun 11 — IV 52% · EM ±5.8%Jun 12 — IV 57% · EM ±5.8%Jun 15 — IV 74% · EM ±5.3%Jun 16 — IV 58% · EM ±3.4%Jun 17 — IV 70% · EM ±2.9%Jun 19 — IV 45% · EM ±10.0%Jun 22 — IV 43% · EM ±9.0%Jun 23 — IV 42% · EM ±8.7%Jun 24 — IV 46% · EM ±9.3%Jun 25 — IV 46% · EM ±9.0%Jun 26 — IV 42% · EM ±8.1%Jun 29 — IV 43% · EM ±7.7%Jun 30 — IV 45% · EM ±7.7%Jul 01 — IV 43% · EM ±7.2%Jul 02 — IV 27% · EM ±4.4%Jul 03 — IV 28% · EM ±4.4%Jul 06 — IV 47% · EM ±6.5%Jul 07 — IV 38% · EM ±5.0%Jul 08 — IV 49% · EM ±6.1%Jul 09 — IV 46% · EM ±5.5%Jul 10 — IV 43% · EM ±4.7%Jul 13 — IV 52% · EM ±4.3%Jul 14 — IV 52% · EM ±3.8%Jul 15 — IV 86% · EM ±5.1%Jul 16 — IV 69% · EM ±2.9%Jul 20 — IV 57% · EM ±13.4%Jul 21 — IV 58% · EM ±13.5%Jul 22 — IV 56% · EM ±12.9%Jul 23 — IV 58% · EM ±13.1%Jul 24 — IV 58% · EM ±12.7%Jul 27 — IV 60% · EM ±12.6%Jul 28 — IV 65% · EM ±13.4%Jul 29 — IV 63% · EM ±12.6%Jul 30 — IV 72% · EM ±14.2%Jul 31 — IV 61% · EM ±11.7%Aug 03 — IV 72% · EM ±12.7%Aug 04 — IV 75% · EM ±12.8%Aug 05 — IV 49% · EM ±8.2%Aug 06 — IV 54% · EM ±8.8%Aug 07 — IV 33% · EM ±5.2%Aug 10 — IV 46% · EM ±6.4%Aug 11 — IV 195% · EM ±25.7%Aug 12 — IV 43% · EM ±5.3%Aug 13 — IV 37% · EM ±4.4%Aug 14 — IV 40% · EM ±4.4%Aug 17 — IV 73% · EM ±6.1%Aug 18 — IV 57% · EM ±4.1%Aug 19 — IV 82% · EM ±4.9%Aug 20 — IV 155% · EM ±6.5%Aug 24 — IV 35% · EM ±7.2%Aug 25 — IV 43% · EM ±8.7%Aug 26 — IV 43% · EM ±8.5%Aug 27 — IV 41% · EM ±8.1%Aug 28 — IV 40% · EM ±7.7%Aug 31 — IV 42% · EM ±7.4%Sep 01 — IV 42% · EM ±7.2%Sep 02 — IV 41% · EM ±6.9%Sep 03 — IV 33% · EM ±5.3%Sep 04 — IV 42% · EM ±6.6%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in